Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?

Subjects

Subjects :

Adjuvants, Immunologic therapeutic use
Humans
Interferon beta-1b
Monitoring, Immunologic
Multiple Sclerosis blood
Autoantibodies blood
Interferon-beta therapeutic use
Multiple Sclerosis drug therapy
Multiple Sclerosis immunology

Details

Language :

English

ISSN :

1745-834X

Volume :

2

Issue :

2

Database :

MEDLINE

Journal :

Nature clinical practice. Neurology

Publication Type :

Academic Journal

Accession number :

16932528

Full Text :

https://doi.org/10.1038/ncpneuro0098